These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 7038963)

  • 21. [Pathogenesis of vascular changes in diabetes].
    Hanzlik J; Kedracka J
    Kardiol Pol; 1976; 29(6):515-20. PubMed ID: 796528
    [No Abstract]   [Full Text] [Related]  

  • 22. [The significance of compensation in diabetes mellitus in the development of diabetic microangiopathies (a review of the literature)].
    Gendeleka GF
    Vrach Delo; 1989 Aug; (8):54-8. PubMed ID: 2686158
    [No Abstract]   [Full Text] [Related]  

  • 23. [Insulin liberation by blood sugar decreasing sulfonamides and by glucose in adult diabetic patients].
    Haupt E; Köberich W; Rosak C; Beyer J; Schöffling K
    Arzneimittelforschung; 1972 Dec; 22():Suppl 12A:2198. PubMed ID: 4198967
    [No Abstract]   [Full Text] [Related]  

  • 24. [Glucose tolerance and insulin secretion in children of both parents diabetic (author's transl)].
    Dvoráková L; Polácková H
    Cas Lek Cesk; 1978 Apr; 117(16):488-92. PubMed ID: 657216
    [No Abstract]   [Full Text] [Related]  

  • 25. Interactions of the IGF System with Diabetes and its Vascular Complications.
    Narayanan RP; Siddals KW; Heald AH; Gibson JM
    Exp Clin Endocrinol Diabetes; 2013 May; 121(5):255-61. PubMed ID: 23430576
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Pathogenesis of angio- and neuropathies in patients with diabetes mellitus].
    Draznin NM
    Sov Med; 1973 Dec; 36(12):17-21. PubMed ID: 4779359
    [No Abstract]   [Full Text] [Related]  

  • 27. Plasma triglycerides in human diabetes.
    Nikkilä EA
    Proc R Soc Med; 1974 Jun; 67(7):662-5. PubMed ID: 4212245
    [No Abstract]   [Full Text] [Related]  

  • 28. Diet-induced improvement of abnormalities in insulin and glucagon secretion and in insulin receptor binding in diabetes mellitus.
    Savage PJ; Bennion LJ; Flock EV; Nagulesparan M; Mott D; Roth J; Unger RH; Bennett PH
    J Clin Endocrinol Metab; 1979 Jun; 48(6):999-1007. PubMed ID: 447806
    [No Abstract]   [Full Text] [Related]  

  • 29. [Changes of lipacidemia in patients with diabetes mellitus of insulin-deficiency type following glucose loading].
    Nocheva M
    Probl Endokrinol (Mosk); 1968; 14(4):3-7. PubMed ID: 5734177
    [No Abstract]   [Full Text] [Related]  

  • 30. The microangiopathic lesions of diabetes mellitus: an evaluation of possible causative factors.
    Merimee TJ; Siperstein MD; Fineberg SE; McKusick VA
    Trans Assoc Am Physicians; 1970; 83():102-12. PubMed ID: 5505385
    [No Abstract]   [Full Text] [Related]  

  • 31. Modulation of insulin secretion in normal and diabetic humans by prostaglandin E and sodium salicylate.
    Robertson RP; Chen M
    Trans Assoc Am Physicians; 1977; 90():353-65. PubMed ID: 347676
    [No Abstract]   [Full Text] [Related]  

  • 32. [Content of sulfhydryl groups in serum of patients with diabetes and in rabbits with alloxan diabetes].
    Bodnar PM
    Fiziol Zh; 1969; 15(6):840-2. PubMed ID: 5386819
    [No Abstract]   [Full Text] [Related]  

  • 33. [Serum triglyceride changes in diabetes mellitus (pathogenetic and diagnostic significance)].
    Hâncu N; Tecuceanu T
    Med Interna (Bucur); 1973 Feb; 25(2):167-77. PubMed ID: 4367691
    [No Abstract]   [Full Text] [Related]  

  • 34. [Blood rheological disorders in diabetes mellitus].
    Galenok VA; Go stinskaia EV; Dikker VE
    Ter Arkh; 1982; 54(10):128-32. PubMed ID: 6758167
    [No Abstract]   [Full Text] [Related]  

  • 35. [Influence of the beta-receptor blocker nifenalol on insulin secretion in normal subjects and diabetic patients (author's transl)].
    Hasslacher C; Wahl P; Riemer G
    Arzneimittelforschung; 1977 Feb; 27(2):426-9. PubMed ID: 577165
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Content and dynamics of sulfhydryl compounds in the blood during treatment of diabetes mellitus].
    Sedov KR; Bobrovskaia LG
    Probl Endokrinol (Mosk); 1979; 25(3):23-6. PubMed ID: 111237
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetic and clinical aspects of intensified subcutaneous insulin therapy.
    Lauritzen T
    Dan Med Bull; 1985 May; 32(2):104-18. PubMed ID: 3924487
    [No Abstract]   [Full Text] [Related]  

  • 38. Increased insulin secretion associated with increased caloric intake in mild noninsulin-dependent diabetics.
    Yingvorapant N; Wendorff H; Field JB
    J Clin Endocrinol Metab; 1980 Jan; 50(1):83-7. PubMed ID: 7350190
    [No Abstract]   [Full Text] [Related]  

  • 39. [Relation between the concentration of zinc in the pancreas and the functional activity of the islets of Langerhans].
    Shevchuk IA; Sanduliak LI
    Probl Endokrinol (Mosk); 1971; 17(6):113-7. PubMed ID: 4948050
    [No Abstract]   [Full Text] [Related]  

  • 40. [Changes in blood sugar, and insulin levels induced by somatostatin in normal, diabetic and acromegalic subjects].
    Carmina E; Lanzara P; Janní A
    Minerva Med; 1976 Apr; 67(18):1204-4-10. PubMed ID: 934480
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.